Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification

Journal of Substance Abuse Treatment - Tập 59 - Trang 99-103 - 2015
Michael D. Stein1,2, Bradley J. Anderson1, Genie L. Bailey2,3
1General Medicine Research Unit, Butler Hospital, Providence, RI 02906
2Warren Alpert Medical School of Brown University, Providence, RI 02912
3Stanley Street Treatment and Resources, Inc., Fall River, Massachusetts, 02720

Tài liệu tham khảo

Amato, 2004, Effectiveness of interventions on opiate withdrawal treatment: An overview of systematic reviews, Drug and Alcohol Dependence, 73, 219, 10.1016/j.drugalcdep.2003.11.002 Amato, 2013, Methadone at tapered doses for the management of opioid withdrawal, Cochrane Database of Systematic Reviews, 2, CD003409 Amato, 2011, Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence, Cochrane Database of Systematic Reviews, 10, CD004147 Bailey, 2013, Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification, Journal of Substance Abuse Treatment, 45, 302, 10.1016/j.jsat.2013.04.002 Bart, 2012, Maintenance medication for opiate addiction: The foundation of recovery, Journal of Addictive Diseases, 31, 207, 10.1080/10550887.2012.694598 Battersby, 2010, Twelve evidence-based principles for implementing self-management support in primary care, Joint Commission Journal on Quality and Patient Safety, 36, 561, 10.1016/S1553-7250(10)36084-3 Broers, 2000, Inpatient opiate detoxification in Geneva: Follow-up at 1 and 6months, Drug and Alcohol Dependence, 58, 85, 10.1016/S0376-8716(99)00063-0 Carrier, 2011, Factors associated with frequent utilization of crisis substance use detoxification services, Journal of Addictive Diseases, 30, 116, 10.1080/10550887.2011.554776 Chutuape, 2001, One-, three-, and six-month outcomes after brief inpatient opioid detoxification, American Journal of Drug and Alcohol Abuse, 27, 19, 10.1081/ADA-100103117 Coleman, 2009, Evidence on the chronic care model in the new millennium, Health affairs (Project Hope), 28, 75, 10.1377/hlthaff.28.1.75 Collins, 2007, Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation, Journal of Substance Abuse Treatment, 32, 167, 10.1016/j.jsat.2006.03.018 Conner, 2011, Treating opioid use under California's Proposition 36: Differential outcomes by treatment modality, Journal of Psychoactive Drugs, 77, 10.1080/02791072.2011.602281 Cunningham, 2011, A comparison of buprenorphine induction strategies: Patient-centered home-based inductions versus standard-of-care office-based inductions, Journal of Substance Abuse Treatment, 40, 349, 10.1016/j.jsat.2010.12.002 Degenhardt, 2011, Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies, Addiction, 106, 32, 10.1111/j.1360-0443.2010.03140.x Degenhardt, 2013, Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010, Lancet, 382, 1564, 10.1016/S0140-6736(13)61530-5 Drummond, 2009, Treatment services for alcohol use disorders Franklin, 2012, Bending the prescription opioid dosing and mortality curves: Impact of the Washington State opioid dosing guideline, American Journal of Industrial Medicine, 55, 325, 10.1002/ajim.21998 French, 2000, Benefit-cost analysis of residential and outpatient addiction treatment in the State of Washington, Evaluation Review, 24, 609, 10.1177/0193841X0002400603 Ghodse, 2010 Gossop, 1995, The treatment mapping survey; A descriptive study of drug and alcohol treatment responses in 23 countries, Drug and Alcohol Dependence, 39, 7, 10.1016/0376-8716(95)01126-J Gossop, 1999, Treatment retention and 1year outcomes for residential programmes in England, Drug and Alcohol Dependence, 57, 89, 10.1016/S0376-8716(99)00086-1 Haley, 2011, Performance contracting to engage detoxification-only patients into continued rehabilitation, Journal of Substance Abuse Treatment, 40, 123, 10.1016/j.jsat.2010.09.001 Holm, 1979, A simple sequentially rejective multiple test procedure, Scandinavian Journal of Statistics, 6, 65 Hubbard, 2003, Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS), Journal of Substance Abuse Treatment, 25, 125, 10.1016/S0740-5472(03)00130-2 Hubbard, 1989 Kertesz, 2009, Housing first for homeless persons with active addiction: Are we overreaching?, Milbank Quarterly, 87, 495, 10.1111/j.1468-0009.2009.00565.x Krupitsky, 2011, Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicentre randomised trial, Lancet, 377, 1506, 10.1016/S0140-6736(11)60358-9 Lundgren, 2006, How do treatment repeaters use the drug treatment system? An analysis of injection drug users in Massachusetts, Journal of Substance Abuse Treatment, 30, 121, 10.1016/j.jsat.2005.10.007 Luty, 2004, Treatment preferences of opiate-dependent patients, Psychiatric Bulletin, 28, 47, 10.1192/pb.28.2.47 Mark, 2002, Trends in inpatient detoxification services, 1992-1997, Journal of Substance Abuse Treatment, 23, 253, 10.1016/S0740-5472(02)00271-4 Mark, 2003, Factors associated with the receipt of treatment following detoxification, Journal of Substance Abuse Treatment, 24, 299, 10.1016/S0740-5472(03)00039-4 Mattick, 2014, Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database of Systematic Reviews, 2, CD002207 Mattick, 1996, Are detoxification programmes effective?, Lancet, 347, 97, 10.1016/S0140-6736(96)90215-9 McCarty, 2008, Treatment programs in the National Drug Abuse Treatment Clinical Trials Network, Drug and Alcohol Dependence, 92, 200, 10.1016/j.drugalcdep.2007.08.004 McKay, 1995, An examination of the cocaine relapse process, Drug and Alcohol Dependence, 38, 35, 10.1016/0376-8716(95)01098-J Mee-Lee, 2009, The ASAM placement criteria and matching patients to treatment, 387 National Collaborating Centre for Mental Health, 2008 National Institute on Alcohol Abuse and Alcoholism, 2005 Orford, 2001, Addiction as excessive appetite, Addiction, 96, 15, 10.1046/j.1360-0443.2001.961152.x Reifler, 2012, Do prescription monitoring programs impact state trends in opioid abuse/misuse?, Pain Medicine, 13, 434, 10.1111/j.1526-4637.2012.01327.x Ridge, 2009, Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence, Journal of Substance Abuse Treatment, 37, 95, 10.1016/j.jsat.2008.09.007 Rosen, 2000, Six- and ten-item indexes of psychological distress based on the Symptom Checklist-90, Assessment, 7, 103, 10.1177/107319110000700201 Simpson, 1997, Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS), Psychology of Addictive Behaviors, 11, 294, 10.1037/0893-164X.11.4.294 Simpson, 1982, Effectiveness of treatment for drug abuse: An overview of the DARP research program, Advances in Alcohol & Substance Abuse, 2, 7, 10.1300/J251v02n01_02 Smyth, 2010, Lapse and relapse following inpatient treatment of opiate dependence, Irish Medical Journal, 103, 176 Sohler, 2010, Home- versus office-based buprenorphine inductions for opioid-dependent patients, Journal of Substance Abuse Treatment, 38, 153, 10.1016/j.jsat.2009.08.001 Specka, 2011, Prediction of the outcome of inpatient opiate detoxification treatment: Results from a multicenter study, European Addiction Research, 17, 178, 10.1159/000324873 Stein, 2015, Comparing the life concerns of prescription opioid and heroin users, Journal of Substance Abuse Treatment, 48, 43, 10.1016/j.jsat.2014.07.001 Substance Abuse and Mental Health Services Administration, 2004 Substance Abuse and Mental Health Services Administration, 2013 Teesson, 2006, Outcomes after detoxification for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS), Drug and Alcohol Review, 25, 241, 10.1080/09595230600657733 Teesson, 2006, One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS), Drug and Alcohol Dependence, 83, 174, 10.1016/j.drugalcdep.2005.11.009 Tiet, 2007, Treatment setting and baseline substance use severity interact to predict patients' outcomes, Addiction, 102, 432, 10.1111/j.1360-0443.2006.01717.x Tuten, 2012, Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification, Addiction, 107, 973, 10.1111/j.1360-0443.2011.03750.x Tuten, 2007, Aftercare plans of inpatients undergoing detoxification, American Journal of Drug and Alcohol Abuse, 33, 547, 10.1080/00952990701407454 U.S. Census Bureau U.S. Department of Health and Human Services, 1995, Detoxification from alcohol and other drugs: Treatment improvement protocol (TIP) series 19 Volkow, 2014, Medication-assisted therapies--tackling the opioid-overdose epidemic, New England Journal of Medicine, 370, 2063, 10.1056/NEJMp1402780 Wang, 1999, Regional brain metabolic activation during craving elicited by recall of previous drug experiences, Life Sciences, 64, 775, 10.1016/S0024-3205(98)00619-5 Watkins, 2003, Using the chronic care model to improve treatment of alcohol use disorders in primary care settings, Journal of Studies on Alcohol, 64, 209, 10.15288/jsa.2003.64.209 World Health Organization, 2009 Wu, 2010, Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network, Journal of Substance Abuse and Rehabilitation, 2010, 13, 10.2147/SAR.S15151